Caractérisation des arythmies cardiaques

Realização e validação de questionários, designadamente de atitude, de conhecimentos, de grau de cumprimento da terapêutica instituída, aceitação da doença, etc, ser de grande interesse na adequação do tratamento a estabelecer, assim como na realização de outros trabalhos científicos.

Estas sugestões são apenas ideias, que necessitam de ser desenvolvidas e estudadas. Penso que podem ajudar a preparar, e quem sabe, encontrar dados e modos de funcionamento que optimizem cada vez mais o atendimento nutricional hospitalar.

BIBLIOGRAFIA

1. Close EJ, Wiles PG, Lockton JÁ, Wlamsley D, Wales JK. Diabetic diets and nutritional recommendations: What happens in real life?. Diabetic med 1992; 9; pp 181-8;

2. Z. Jorge, E. Lacerda Nobre, A. Macedo, J. Jacôme de Castro. Prevalência da Diabetes mellitus tipo 1 em Portugal - 1995-1999. Acta Médica Portuguesa 2003, 16: pp 251-253;

3. Lebovitz HE. Objectivos del tratamiento. Introduccion In: Lebovitz HE. Tratamiento de la Diabetes mellitus y sus complicaciones. Tercera edicion. Barcelona: Medical Trends 1998: pp 1;

4. Venkat Narayan KM, Bowman BA, Engelgau ME. Prevention of type 2 diabetes. British Medical Journal 2001, vol. 323: pp 63;

5. Barbara B. Fleming, Sheldon Greenfield, Michael M. Engelgau, Leonard M. Pogach, Steven B. Clauser, Marian A. Parrott. The Diabetes Quality Improvement Project. Diabetes Care 2001, vol. 24, n.° 10: pp 1815;

6. Joe V. Selby, Andrew J. Karter, Lynn M. Ackerson, Assiamira Ferrara, Jennifer Liu. Developing a prediction rule from automated clinical databases to identify high-risk patients in a large population with diabetes. Diabetes Care 2001, vol. 24: pp 1547-1555;

7. American Diabetes Association: Report of the Expert Committe on the diagnosis and Classification of Diabetes mellitus. Diabetes care 2003, vol 26, suppl 1: pp s5; 8. Alberti KGMM, Zimmet PZ for the WHO consultation. Definition, diagnosis and classification of Diabetes mellitus and its complications. Publicação não formal da OMS 1999: p p 1 ;

9. American Diabetes Association: Report of the Expert Committe on the diagnosis and Classification of Diabetes mellitus. Diabetes care 2001, vol 24, suppl 1: pp s12-s13);

10. Grupo de estudos da Diabetes mellitus da SPEDM. Definição, Diagnóstico, Classificação e Nomenclatura da Diabetes mellitus. Arquivos de Medicina 2002, Vol. 16 (separata): pp 235-240;

11. Direcção Geral da Saúde. Actualização dos Critérios de Classificação e Diagnóstico da Diabetes mellitus. Circular normativa n.° 09/DGCG, 2002;

12. American Diabetes Association. Standards of Medical Care for Patients with Diabetes mellitus. Diabetes care 2003, vol 26, suppl 1 : pp s33-s50;

13. Sociedade Portuguesa de Diabetologia, Direcção-Geral de Saúde. Programa de Controlo da Diabetes mellitus - Dossier Diabetes: em conjunto objectivos comuns, 1998;

14. Holzmeister LA. Children and Adolescents. Cap. 25 In: Powers MA. Handbook of Diabetes Medical Nutrition Therapy. 2nd ed. Gaithersburg, Maryland: Aspen Publishers, 1996: pp 473-502;

15 . Bott U, Schattenberg S, Muhlhauser I, Berger M. The Diabetes Care Team: A Holistic Approach. Diabetes reviews international 1996, 5: 12-14;

16. Grupo de consenso europeu sobre a DMID. Consensus Guidelines. Orientações de Consenso para o Controlo da Diabetes Mellitus Insulino- dependente (tipo 1). Bussum: Medicom Europe BV, 1993;

17. American Diabetes Association. Intensive Diabetes Management. Alexandria: American Diabetes Association, 1995;

18. Hirsch RF, Hirsch IB. Papel del educador de diabetes en el cuidado del paciente. Cap. 13 In: Lebovitz HE. Tratamiento de la Diabetes mellitus y sus complicaciones. Tercera edicion. Barcelona: Medical Trends, 1998: pp 83-86; 19. Bayless M, Martin C. The Team approach to Intensive Diabetes Management. Diabetes Spectrum 1998; 11: pp 33-37;

20. American Diabetes Association. Diabetes Management in Different Life Stages. Cap. VII In: American Diabetes Association. Maximizing the Role of Nutrition in Diabetes Management. USA: American Diabetes Association 1994: pp 43-53;

21. Figuerola D. Hablemos de la Comunicacion com los Pacientes. Primera edicion. Barcelona: acv ediciones, 1997;

22. Pastors JG, Warshaw H, Daly A, Franz M, Kulkarni K. The evidence for the efectiveness of Medical Nutrition Therapy in Diabetes management. Diabetes Care 2002, vol. 25, n.° 3: pp 608-613;

23. American Diabetes Association. Evidence-Based Nutrition Principles and Recommendations for the Treatment and Prevention of Diabetes and Related Complications. Diabetes care 2003, vol 26, suppl 1: pp s51-s61;

24. Daly A, Powers M. Tratamiento nutricional médico. Cap. 16 In: Lebovitz HE. Tratamiento de la Diabetes mellitus y sus complicaciones. Tercera edicion. Barcelona: Medical Trends 1998: pp 98-106;

25. Powers MA. Medical Nutrition Therapy for Diabetes. Cap. 3 In: Handbook of Diabetes Medical Nutrition Therapy. 2nd ed. Gaithersburg, Maryland: Aspen

26. Expert Panel on the Identification, Evaluation and Treatment of overweight and obesity in Adults. The Praticai Guide - Identification, Evaluation and Treatment of overweight and obesity in Adults. National Health Institutes 2000, publication number 00-4084: pp 1 ;

27. American Diabetes Association. Treatment of Hypertension in Adults with Diabetes. Diabetes Care 2003, vol. 26 (suppl. 1): pp s80-s82;

28. Makinlay J, Marceau L. US public health and 21st century: diabetes mellitus. Lancet 2000; 356: pp 757-761;

29. Campbell SM, Hann M, Hacker J, Burns C, Oliver D, Thapor A, Mead N, Gels Safran D, Roland MO. Identifying predictors of high quality care in English general practice: observational study. British Medical Journal 2001, vol. 323: pp 1-6;

30. American Association of Clinical Endocrinologists. AAEC Diabetes Guidelines. Endocrine Practice 2002; vol. 8 (suppl. 1): pp 40-82;

31. Clark Jr. CM, Snyder JW, Meer RL, Stutz LM, Parkin CG. A systematic Approach to Risk Stratification and Intervention Within a Managed Care

Environment improves Diabetes outcomes and Patient satisfaction. Diabetes Care 2001, vol.24, n.°6: pp 1079-1086;

32. Stratton IM, Adler AI, Neil HAW, Mathews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. British Medical Journal 2000, vol. 321: pp 405-412;

33. Davidson MB. How do we diagnose Diabetes and measure Blood Glucose Control?: A clinical basis for the diagnosis of Diabetes. Diabetes Spectrum 2001, vol. 14, n.°2:pp67-71;

34. American Diabetes Association. Implications of the Diabetes Control and Complications Trial. Diabetes Care 2003, vol. 26 (suppl. 1):s25-s27;

35. American Diabetes Association. Implications of the United Kingdom Prospective Diabetes Study. Diabetes Care 2003, vol. 26 (suppl. 1):s28-s32;

36. Renders CM, Valk GD, Griffin SJ, Wagner EH, Eijk Van JT, Assendelft WJJ. Interventions to improve the management of Diabetes in Primary Care, Outpatient, and Community Settings. Diabetes Care 2001, vol. 24, n.° 10: pp 1831-1833;

37. Narayan KMV, Gregg EW, Fagot-Campagna A, Engelgau MM, Vinicor F. Diabetes: a common, serious, costly, and potentially preventable public health problem. Diabetes Research and Clinical Practice 2000, vol.50: pp 77-84;

38. Wolpert HÁ, Anderson BJ. Metabolic Control Matters: Why is the message lost in the translation? Diabetes Care 2001, vol. 24, n.° 7: pp 1301-1303;

39. Bower P, Campbell S, Bojke C, Sibbald B. Team structure, team climate and the quality of care in primary care: an observational study. Quality and Safety in Health Care 2003; 12: pp 273-279;

40. Hernández-Ronquillo L, Tellez-Zentano SF, Garduno-Espinoza J, González- Acerez E. Factors associated with therapy non-compliance in type 2 diabetes. Salud Pública de México 2003, vol. 45: pp 191-197.

Data de nascimento / /

Idade actual anos

Sexo Masculino O Feminino f j

Altura m

Idade aquando o início das consultas de nutrição anos

Tipo de Diabetes Tipo 1 D Tipo 2 D Outro tipo D Data de diagnóstico / /

Tempo de evolução até à Ia consulta de nutrição anos

Regime de tratamento Insulina Q ADO □ Insulina e ADOO Outro □

Qual: Valores laboratoriais Data de recolha / / / / / / / / / / HbAjC / / / / / / / / / / HbAjC Data de recolha / / / / / / / / / / Colesterol Total Colesterol HDL Triglicerídeos Creatinina Microalbuminuria Pressão Arterial N.° de medições efectuadas:

Pressão sistólica Pressão Diastólica < 130 mg Hg < 80 mm Hg

130 a 139 mg Hg 80 a 89 mm Hg >= 140 mg Hg >= 90 mm Hg

Outras patologias associadas

HTA O Dislipidemia Q Obesidade Q Outras Q Quais:

Complicações derivadas da diabetes

Retinopatia Q Nefropatia Q Neuropatia Q Pé diabético □

Data da 1* consulta de Diabetologia / /

N.° de consultas de Diabetologia Abandonou a consulta: Sim Q Não □ Data da Ia consulta de Nutrição / /

N.° de consultas de nutrição Abandonou a consulta: Sim □ Não D Peso na Ia consulta de nutrição kg